AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9597413 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group 3)
Number of subjects: 634
Study 7822059 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fluoride toothpaste (550 ppm)
Number of subjects: 1523
Study 7822059 — intervention group
Group type: COMPARATOR
Intervention: Standard fluoride toothpaste (1050 ppm)
Number of subjects: 1523
Study 3171790 — intervention group
Group type: EXPERIMENTAL
Intervention: Dhaka solution with dextrose (DS + D)
Number of subjects: 67
Study 3171790 — intervention group
Group type: COMPARATOR
Intervention: Dhaka solution without dextrose (DS)
Number of subjects: 67
Study 30868637 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 14
Study 30868637 — intervention group
Group type: COMPARATOR
Intervention: Standard sural NCS
Number of subjects: 14
Study 28419200 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV)
Number of subjects: 298
Study 28419200 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir-boosted Lopinavir (LPV/r)
Number of subjects: 298
Study 26106114 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy (16 hours per week for 3 weeks)
Number of subjects: 34
Study 26106114 — intervention group
Group type: COMPARATOR
Intervention: Distributed therapy (6 hours per week for 8 weeks)
Number of subjects: 34
Study 23675629 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to electromagnetic radiation from a 2.4-GHz cordless phone base station (3‐8 µW/cm²) for 3‐min intervals
Number of subjects: 69
Study 22069964 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic decompression via unilateral approach (group B)
Number of subjects: 79
Study 22069964 — intervention group
Group type: COMPARATOR
Intervention: Posterior lamina fenestration decompression (group A)
Number of subjects: 79
Study 19218185 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized, single-session intervention delivered by a lay health adviser
Number of subjects: 266
Study 19218185 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 266
Study 17875958 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperuricemia (serum uric acid level, >7.0 mg/dL)
Number of subjects: 283
Study 17875958 — intervention group
Group type: EXPERIMENTAL
Intervention: History of gout
Number of subjects: 283
Study 17875958 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 283
Study 17875958 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 283
Study 14759231 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate 2000/125 mg twice daily
Number of subjects: 1295
Study 14759231 — intervention group
Group type: COMPARATOR
Intervention: Comparators (levofloxacin 500 mg once daily, clarithromycin 500 mg twice daily, amoxicillin/clavulanate 875/125 mg, and 1000/125 mg)
Number of subjects: 1295
Study 14759231 — intervention group
Group type: COMPARATOR
Intervention: Comparators
Number of subjects: 1295
Study 11567761 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL-12 (1 or 4 microg)
Number of subjects: 34
Study 11567761 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 9632129 — intervention group
Group type: EXPERIMENTAL
Intervention: Running shoe with optimized forefoot pressure damping
Number of subjects: 0
Study 9632129 — intervention group
Group type: COMPARATOR
Intervention: Custom-made soft insole
Number of subjects: 0
Study 9632129 — intervention group
Group type: COMPARATOR
Intervention: Oxford shoe
Number of subjects: 0
Study 7868986 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol, 2 mg daily
Number of subjects: 8
Study 7868986 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol, 0.1 mg twice weekly
Number of subjects: 8
Study 7868986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 3336615 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle suspension method
Number of subjects: 20
Study 3336615 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh suspension method
Number of subjects: 20
Study 3336615 — intervention group
Group type: COMPARATOR
Intervention: Both methods (ankle and thigh suspension)
Number of subjects: 20
Study 28934746 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal temperature probe placement
Number of subjects: 122
Study 28934746 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic temperature probe placement
Number of subjects: 122
Study 28934746 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary temperature probe placement
Number of subjects: 122
Study 27211991 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 586
Study 27211991 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance Education and Twelve-Step Introduction (SET)
Number of subjects: 586
Study 25926532 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic AZA initiated ≤2 weeks from surgery
Number of subjects: 63
Study 25926532 — intervention group
Group type: COMPARATOR
Intervention: Endoscopy-driven AZA initiated only in case of endoscopic recurrence (Rutgeerts' score ≥i2) at weeks 26 or 52
Number of subjects: 63
Study 22692502 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-months aged lysozyme-containing cheese
Number of subjects: 21
Study 22692502 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-months aged lysozyme-containing cheese
Number of subjects: 21
Study 22692502 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysozyme-specific IgE level higher than 7 kU/L
Number of subjects: 21
Study 22692502 — intervention group
Group type: COMPARATOR
Intervention: Grana Padano cheese (not specified if lysozyme-containing)
Number of subjects: 21
Study 21658562 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D therapy (high responders)
Number of subjects: 0
Study 21658562 — intervention group
Group type: COMPARATOR
Intervention: ICD-only patients
Number of subjects: 0
Study 21658562 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D therapy (low responders)
Number of subjects: 0
Study 21658562 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous measure of CRT-D response
Number of subjects: 0
Study 19454868 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary (behavioral‐medical) rehabilitation alone
Number of subjects: 363
Study 19454868 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation with subsequent booster sessions
Number of subjects: 363
Study 19454868 — intervention group
Group type: COMPARATOR
Intervention: Traditional orthopedic rehabilitation
Number of subjects: 363
Study 16684435 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver textile (Group 1)
Number of subjects: 30
Study 16684435 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednicarbate ointment (Group 3)
Number of subjects: 30
Study 16684435 — intervention group
Group type: COMPARATOR
Intervention: Silver-free textile (Group 2)
Number of subjects: 30
Study 15230485 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavones (90 mg daily for 6 weeks)
Number of subjects: 40
Study 11299246 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous fluid-filled catheter
Number of subjects: 19
Study 11299246 — intervention group
Group type: COMPARATOR
Intervention: Balloon-tipped catheter
Number of subjects: 19
Study 7673989 — intervention group
Group type: EXPERIMENTAL
Intervention: Metastatic renal cell carcinoma patients with brain metastases (asymptomatic)
Number of subjects: 90
Study 7673989 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent cases of asymptomatic brain lesions
Number of subjects: 90
Study 2096518 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin 100 micrograms/kg or greater
Number of subjects: 40
Study 352376 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0
Study 352376 — intervention group
Group type: EXPERIMENTAL
Intervention: Debrisoquine
Number of subjects: 0
Study 31979305 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg of EGCG and 60 mL of coconut oil
Number of subjects: 51
Study 31979305 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 51
Study 30109588 — intervention group
Group type: EXPERIMENTAL
Intervention: Huannao Yicong Formula (HYF) 5 g granules twice daily
Number of subjects: 60
Study 30109588 — intervention group
Group type: COMPARATOR
Intervention: Donepezil 5 mg once daily
Number of subjects: 60
Study 28345499 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplement
Number of subjects: 50
Study 28345499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 25624756 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training, 3 sessions per week for 12 weeks
Number of subjects: 11
Study 25624756 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training
Number of subjects: 11
Study 25624756 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) without intervention
Number of subjects: 11
Study 24372674 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg tamsulosin once a day
Number of subjects: 108
Study 24372674 — intervention group
Group type: COMPARATOR
Intervention: Conservative management only
Number of subjects: 108
Study 22510279 — intervention group
Group type: EXPERIMENTAL
Intervention: Paula method (circular muscle exercises)
Number of subjects: 126
Study 22510279 — intervention group
Group type: COMPARATOR
Intervention: Pelvic floor muscle training (PFMT) exercises
Number of subjects: 126
Study 20053273 — intervention group
Group type: EXPERIMENTAL
Intervention: WE CALL (multimodal support intervention comprising information, education and telephone support)
Number of subjects: 384
Study 20053273 — intervention group
Group type: COMPARATOR
Intervention: YOU CALL (passive intervention providing the name and phone number of a resource person)
Number of subjects: 384
Study 18350737 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 34
Study 18350737 — intervention group
Group type: COMPARATOR
Intervention: Orlistat
Number of subjects: 34
Study 15361892 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 85
Study 15361892 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 85
Study 15361892 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 85
Study 15361892 — intervention group
Group type: COMPARATOR
Intervention: Nonstatin antihyperlipidaemic drug
Number of subjects: 85
Study 15361892 — intervention group
Group type: EXPERIMENTAL
Intervention: All four antihyperlipidaemic drugs
Number of subjects: 85
Study 15361892 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin groups (Fluvastatin, Simvastatin, Pravastatin)
Number of subjects: 85
Study 15361892 — intervention group
Group type: COMPARATOR
Intervention: Nonstatin group
Number of subjects: 85
Study 11882512 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dideuterated Delta(5)-phytosterols and oral pentadeuterated Delta(5)-phytosterols
Number of subjects: 10
Study 11882512 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of soy stanols
Number of subjects: 10
Study 10572324 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50-150 mg)
Number of subjects: 238
Study 10572324 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20-60 mg)
Number of subjects: 238
Study 10572324 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 238
Study 10572324 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 238
Study 8926268 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.2 MJ/day diet plus aerobic and anaerobic exercise
Number of subjects: 69
Study 8926268 — intervention group
Group type: COMPARATOR
Intervention: 4.2 MJ/day diet
Number of subjects: 69
Study 2071428 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting shower
Number of subjects: 30
Study 2071428 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting sink bath
Number of subjects: 30
Study 2071428 — intervention group
Group type: COMPARATOR
Intervention: Bathing activity (both methods)
Number of subjects: 30
Study 6403172 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 14
Study 6403172 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation of cold air
Number of subjects: 14
Study 6403172 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation of room air
Number of subjects: 14
Study 6403172 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of ultrasonically nebulised distilled water
Number of subjects: 14
Study 31031050 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved study features with 90% attendance in volunteer-based centers and 70% in population-based centers
Number of subjects: 0
Study 31031050 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-year screen interval
Number of subjects: 0
Study 31031050 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% biopsy compliance
Number of subjects: 0
Study 31031050 — intervention group
Group type: COMPARATOR
Intervention: 30% attendance
Number of subjects: 0
Study 31031050 — intervention group
Group type: COMPARATOR
Intervention: 40% biopsy compliance
Number of subjects: 0
Study 31031050 — intervention group
Group type: COMPARATOR
Intervention: 100% contamination
Number of subjects: 0
Study 29365017 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (successful reperfusion)
Number of subjects: 462
Study 29365017 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (successful recanalization)
Number of subjects: 462
Study 29365017 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed reperfusion or lower Alberta Stroke Program Early Computed Tomography Score
Number of subjects: 462
Study 29365017 — intervention group
Group type: COMPARATOR
Intervention: No reperfusion or recanalization
Number of subjects: 462
Study 26778346 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement in visual acuity (VA)
Number of subjects: 284
Study 26778346 — intervention group
Group type: EXPERIMENTAL
Intervention: Short time per specialist visit
Number of subjects: 284
Study 26778346 — intervention group
Group type: EXPERIMENTAL
Intervention: Change of VA
Number of subjects: 284
Study 26778346 — intervention group
Group type: EXPERIMENTAL
Intervention: Waiting, treatment, and travel time
Number of subjects: 284
Study 26778346 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment scheme
Number of subjects: 284
Study 26778346 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to accept time per physician visit
Number of subjects: 284
Study 25088843 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with alteplase at 0.6 mg/kg body weight
Number of subjects: 0
Study 25088843 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 21369794 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐TCP/Clg non‐membrane
Number of subjects: 20
Study 21369794 — intervention group
Group type: COMPARATOR
Intervention: β‐TCP/Clg + barrier membrane
Number of subjects: 20
Study 19082836 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxy-methylated cellulose (CMC) nasal packing
Number of subjects: 41
Study 19082836 — intervention group
Group type: COMPARATOR
Intervention: No nasal packing (control)
Number of subjects: 41
Study 17304142 — intervention group
Group type: EXPERIMENTAL
Intervention: LiftTrainer program (behavior-based lift training)
Number of subjects: 2144
Study 17304142 — intervention group
Group type: COMPARATOR
Intervention: Video control group
Number of subjects: 2144
Study 17304142 — intervention group
Group type: EXPERIMENTAL
Intervention: LiftTrainer program (for those with low twisting moments <30 Nm)
Number of subjects: 2144
Study 17304142 — intervention group
Group type: COMPARATOR
Intervention: Video control group (for those with low twisting moments <30 Nm)
Number of subjects: 2144
Study 15341352 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF plus EMD
Number of subjects: 17
Study 15341352 — intervention group
Group type: COMPARATOR
Intervention: CAF only
Number of subjects: 17
Study 11180034 — intervention group
Group type: EXPERIMENTAL
Intervention: Seville orange juice
Number of subjects: 10
Study 11180034 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilute grapefruit juice
Number of subjects: 10
Study 11180034 — intervention group
Group type: COMPARATOR
Intervention: Common orange juice (control)
Number of subjects: 10
Study 11180034 — intervention group
Group type: EXPERIMENTAL
Intervention: 6',7'-dihydroxybergamottin
Number of subjects: 10
Study 11180034 — intervention group
Group type: EXPERIMENTAL
Intervention: Bergapten
Number of subjects: 10
Study 9675717 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposed subjects to 2-alkoxyethanols and their acetates
Number of subjects: 0
Study 9675717 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 9414362 — intervention group
Group type: EXPERIMENTAL
Intervention: Box size variations (300, 450, 600 mm) and lifting frequency (1, 4, 6 lifts/min)
Number of subjects: 13
Study 9414362 — intervention group
Group type: EXPERIMENTAL
Intervention: Box size variations and lifting frequency
Number of subjects: 13
Study 9414362 — intervention group
Group type: COMPARATOR
Intervention: Chinese inexperienced male subjects
Number of subjects: 13
Study 9414362 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifting frequency
Number of subjects: 13
Study 9414362 — intervention group
Group type: COMPARATOR
Intervention: Chinese and Occidental subjects
Number of subjects: 13
Study 9414362 — intervention group
Group type: EXPERIMENTAL
Intervention: Body part RPE ratings
Number of subjects: 13
Study 2718223 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg/day)
Number of subjects: 21
Study 2718223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 334500 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin (5000 IU daily, twice)
Number of subjects: 362
Study 334500 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined heparin and dihydroergotamine (5000 IU heparin and 0.5 mg dihydroergotamine daily)
Number of subjects: 362
Study 334500 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prophylactic treatment)
Number of subjects: 362
Study 28383172 — intervention group
Group type: EXPERIMENTAL
Intervention: Ti‐250 μm (group D)
Number of subjects: 100
Study 28383172 — intervention group
Group type: COMPARATOR
Intervention: Ti‐no air abrasion (group A)
Number of subjects: 100
Study 28383172 — intervention group
Group type: EXPERIMENTAL
Intervention: Ti‐110 μm (group C)
Number of subjects: 100
Study 28383172 — intervention group
Group type: EXPERIMENTAL
Intervention: Ti‐air‐abraded with 50 μm (group B)
Number of subjects: 100
Study 28383172 — intervention group
Group type: EXPERIMENTAL
Intervention: Co‐Cr‐50 μm (group E)
Number of subjects: 100
Study 28657801 — intervention group
Group type: EXPERIMENTAL
Intervention: 20mg melatonin gargle before each irradiation and 20mg melatonin capsules nightly during 7 weeks of concurrent chemoradiation
Number of subjects: 39
Study 28657801 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 39
Study 26281607 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose group (112 patients) for acute diarrhea
Number of subjects: 507
Study 26281607 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose group (113 patients) for acute diarrhea
Number of subjects: 507
Study 26281607 — intervention group
Group type: COMPARATOR
Intervention: Positive control group (115 patients) for acute diarrhea
Number of subjects: 507
Study 26281607 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose group (56 patients) for chronic persistent diarrhea
Number of subjects: 507
Study 26281607 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose group (55 patients) for chronic persistent diarrhea
Number of subjects: 507
Study 26281607 — intervention group
Group type: COMPARATOR
Intervention: Control group (56 patients) for chronic persistent diarrhea
Number of subjects: 507
Study 22930219 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week home-based walking program
Number of subjects: 32
Study 22930219 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 22930219 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (independent of study group)
Number of subjects: 32
Study 22254076 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 400 µg/day
Number of subjects: 144
Study 22254076 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 140 µg/day
Number of subjects: 144
Study 22254076 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 19929183 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity on Prescription (PAP) programme with exercise twice a week, education, and motivational counselling
Number of subjects: 525
Study 19929183 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 525
Study 19929183 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity on Prescription (PAP) programme
Number of subjects: 525
Study 17046724 — intervention group
Group type: EXPERIMENTAL
Intervention: Delusional Assessment Scale (DAS)
Number of subjects: 92
Study 17046724 — intervention group
Group type: COMPARATOR
Intervention: Brief Psychiatric Rating Scale (BPRS)
Number of subjects: 92
Study 12717237 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabbit antithymocyte globulin (RATG) 1.5 mg/kg during the anhepatic phase followed by 1.5 mg/kg on posttransplant day 1
Number of subjects: 119
Study 12717237 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone 1,000 mg followed by a 3-month steroid taper
Number of subjects: 119
Study 10657415 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen for secondary stroke prevention
Number of subjects: 644
Study 10657415 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes-adjusted guidelines (<130/85 mm Hg for diabetics, <140/90 mm Hg for nondiabetics)
Number of subjects: 644
Study 9404752 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual Volume (RV) method
Number of subjects: 12
Study 9404752 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Residual Capacity (FRC) method
Number of subjects: 12
Study 8304789 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 g dipyrone combined with a spasmolytic agent and 30 mg ketorolac tromethamine
Number of subjects: 34
Study 8304789 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 34